Pharmafile Logo
Pharmafocus logo
Advanced Search

Genzyme buys SangStat for $600m

October 29, 2003
Research and Development

US biotech company Genzyme is to buy SangStat, a California-based company whose lead product Thymoglobulin is a $77 million-a-year treatment …

News

Pfizer/Pharmacia mega-merger gains final clearance

October 29, 2003
Sales and Marketing

The creation of a new pharmaceutical goliath is now just days away after Pfizer and Pharmacia received final regulatory clearance …

News

AstraZeneca prepares Crestor for battle

October 29, 2003
Sales and Marketing

AstraZeneca's US salesforce is gearing up to launch its potential blockbuster cholesterol-reducing drug Crestor, after receiving a long-awaited FDA approval.Crestor …

News

Yamanouchi reinforces US future with GSK deal

October 29, 2003
Sales and Marketing

Japanese pharma company Yamanouchi has struck a deal to co-market its forthcoming overactive bladder treatment with GlaxoSmithKline in the US. …

News

Troubled UK biotechs to merge

October 29, 2003
Research and Development

News

Exanta on NICE list ahead of marketing authorisation

October 29, 2003
Sales and Marketing

AstraZeneca's Exanta is to be in NICE's next programme of appraisals even though the blood-thinning drug has not yet received …

News

Pharma upbeat on the future of online detailing

October 29, 2003
Medical Communications e-detailing, survey

The UK pharma industry remains open-minded about using online detailing, but wants to see more evidence of its effectiveness, a …

Feature

Aventis sues generic rivals over Lovenox

October 29, 2003
Sales and Marketing

Aventis has gone to court in the US to prevent generic versions of its second-biggest drug, blockbuster anti-thrombotic treatment Lovenox, …

News

BMJ puts industry relations under spotlight

October 29, 2003
Sales and Marketing

 Patients would benefit from less involvement between pharmaceutical companies and the medical profession, according to new research.A study of more …

News

BMA presses ahead with make-or-break contract vote

October 29, 2003

News

Parallel imports save NHS millions, say health economists

October 29, 2003
Manufacturing and Production

News

Doctors ask for one more performance indicator

October 29, 2003

An increasing disengagement of GPs from their primary care trusts is threatening to thwart the government's plans for an NHS …

News

Xeloda recommended for breast and colorectal cancer

October 29, 2003
Sales and Marketing

News

Pre-clinical marketing: understanding need

October 29, 2003
Research and Development marketing, pre-clinical

Since the modern pharmaceutical industry emerged, product development has been largely driven by science, with R&D seen almost exclusively as …

Feature

New SSRI inquiry to consider patient experiences

October 29, 2003
Sales and Marketing

The Government has conceded to intense pressure to give patients input into a new inquiry on the safety of SSRI …

News

Investors win battle of JP’s golden parachute

October 29, 2003
Sales and Marketing

News

Audit of NHS obesity services reveals inequalities

October 29, 2003

News

Pele keeps playing for Pfizer

October 29, 2003
Sales and Marketing

Pele has signed up with Pfizer to continue his work on raising awareness of erectile dysfunction for the pharma company.The …

News

GSK international pharma chief leaves for Chiron

October 29, 2003
Sales and Marketing Chiron, David Stout, GSK, Howard Pien

 GlaxoSmithKline’s head of international pharmaceutical operations, Howard Pien, is to leave the company to become Chief Executive of Chiron.Mr Pien’s …

News

GSK pipeline fuelled by purchases

October 29, 2003
Research and Development

GlaxoSmithKline leads the industry in licensing in new drugs, buying the rights to nearly twice as many products as its …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025